Immunopharmacological studies of beta-1,3-glucan
Ríos-Hernández, M.; Dos-Santos, N.J.; Silvia-Cardoso; Bello-Gárciga, J.L.; Pedroso, M.
Archives of Medical Research 25(2): 179-180
1994
ISSN/ISBN: 0188-4409 PMID: 7919808 Document Number: 438454
The influence of a nonsoluble beta-1,3-glucan preparation on the immune response of mice and rats to sheep red blood cells and to phytohemagglutinin A (PHA) T cell mitogen were evaluated. Treatment with glucan increased the hemagglutinin titers in both species and the response of mice spleen cells to PHA.
Document emailed within 1 workday
Related Documents
Kowalczyk-Bronisz, S.H.; Zabska, R. 1986: Studies on the derivatives of aziridine. I. synthesis and immunopharmacological analysis of amides of alpha-aziridinyl- beta-/p-chlorobenzoyl/-propionic acid Archivum Immunologiae et Therapiae Experimentalis 34(3): 333-350Shimbo, M.; Ito, N.; Kadonosono, K. 2002: Investigation of beta-D-glucan values in the vitreous Nippon Ganka Gakkai Zasshi 106(9): 579-582
Yenidogan, E.; Gulcelik, M.A.; Pak, I.; Akgul, G.G.; Colakoglu, M.K.; Alagol, H. 2013: Effects of Beta-d-glucan on diabetic colon anastomosis Wounds: a Compendium of Clinical Research and Practice 25(7): 171-177
Tohamy, A.A.; El-Ghor, A.A.; El-Nahas, S.M.; Noshy, M.M. 2003: Beta-glucan inhibits the genotoxicity of cyclophosphamide, adriamycin and cisplatin Mutation Research 541(1-2): 45-53
Ivanushko, L.A.; Besednova, N.N.; Zaporozhets, T.S.; Zviagintseva, T.N. 2001: 1,3;1,6-beta-D-glucan translam: results of studying and prospects for application Antibiotiki i Khimioterapiia 46(7): 14-18
Takeshita, K.; Fukazawa, I.; Nakaike, S.; Kameo, K.; Tomisawa, K.; Otomo, S.; Aihara, H. 1988: Immunopharmacological studies of new 3-benzoyl-4-mercaptobutyric acid derivatives. II. Immunosuppressive effects Drugs under Experimental and Clinical Research 14(5): 311-318
Chen, J.; Zhang, G. 2002: Dynamics of beta-glucan content during kernel development and its relationship with meteorological factors Ying Yong Sheng Tai Xue Bao 13(4): 417-420
Kato, H.; Nakao, A.; Kambe, T.; Tanaka, K.; Tamura, H.; Tanaka, S.; Takagi, H. 1993: The quantitative assay of (1-->3)-beta-D-glucan in culture medium of Candida albicans using G-test Nihon Geka Gakkai Zasshi 94(4): 329-333
García, M.; Nogués, A.; Herrero, E. 1995: Sensitivity of yeast isolates to amphotericin B and other antifungal inhibitors of beta-glucan synthesis Enfermedades Infecciosas y Microbiologia Clinica 13(3): 151-156
de Felippe Júnior, J.; da Rocha e Silva Júnior, M.; Maciel, F.M.; Soares, A.de.M.; Mendes, N.F. 1993: Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan) Surgery Gynecology and Obstetrics 177(4): 383-388
Cerci, C.; Yildirim, M.; Ceyhan, M.; Bozkurt, S.; Doguc, D.; Gokicimen, A. 2008: The effects of topical and systemic Beta glucan administration on wound healing impaired by corticosteroids Wounds: a Compendium of Clinical Research and Practice 20(12): 341-346
Matsushita, M.; Sankawa, U.; Okuda, T.; Okada, H.; Sasaki, T. 1983: A cleavage product of mouse C3 adsorbable to (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 Japanese Journal of Experimental Medicine 53(5): 219-225
Kusanagi, H.; Shimura, T.; Teramoto, A. 2000: The usefulness of fluconazole administration and beta-D-glucan measurement in neurosurgical patients with deep-seated mycosis No Shinkei Geka. Neurological Surgery 28(8): 685-690
Tsuda, S.; Misawa, S.; Horiike, S.; Hirakawa, K.; Kuzuyama, Y.; Nakai, H.; Seryu, T.; Takashima, T.; Taniwaki, M.; Kashima, K. 1993: Efficacy of fluconazole on systemic mycosis associated with hematologic malignancies and a study on diagnostic value of plasma beta-D-glucan levels Japanese Journal of Antibiotics 46(10): 904-911
Pandey, B.L.; Das, P.K. 1988: Immunopharmacological studies on Picrorhiza kurroa Royle-ex-Benth. Part III: Adrenergic mechanisms of anti-inflammatory action Indian Journal of Physiology and Pharmacology 32(2): 120-125
Bobek, P.; Galbavy, S. 2001: Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine-induced precancerous lesions in rat colon British Journal of Biomedical Science 58(3): 164-168
Walsh, T.J.; Lee, J.W.; Kelly, P.; Bacher, J.; Lecciones, J.; Thomas, V.; Lyman, C.; Coleman, D.; Gordee, R.; Pizzo, P.A. 1991: Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis Antimicrobial Agents and Chemotherapy 35(7): 1321-1328
Rácil, Z.; Kocmanová, I.; Weinbergerová, B.; Winterová, J.; Lengerová, M.; Hrncírová, K.; Mayer, J. 2009: Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results Klinicka Mikrobiologie a Infekcni Lekarstvi 15(2): 48-57
Sasaki, T.; Abiko, N.; Uchida, H.; Tanaka, M.; Nitta, K.; Yoshioka, Y.; Nomura, H. 1983: Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans Cancer Treatment Reports 67(3): 275-280
Einecke, D. 2001: ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker MMW Fortschritte der Medizin 143(26-27): 6